NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Peter Y. Chang, MD, discusses early physician experiences with Xipere triamcinolone acetonide suprachoroidal injection.

Data from the IRIS Registry show that triamcinolone acetonide “performs very well in real-world settings” to treat patients with the condition, he said.

Billing and Ordering TRIESENCE TRIESENCE (J3300 Injection, triamcinolone acetonide, preservative-free, 1 mg) is a single-use vial of 40 milligrams or 40 units based on the HCPCS descriptor.

Flexion Therapeutics Announces FDA Approval of sNDA to Revise ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Product Label Published Dec 26, 2019 4:15pm EST ...

SILVER SPRING, Maryland — A federal advisory panel has voted to allow triamcinolone acetonide (TAA) nasal spray (Nasacort, sanofi-aventis) to be switched from prescription to over-the-counter ...

Clearside Biomedical, Inc. Reports Efficacy and Safety Results in Non-infectious Uveitis Using a Single Suprachoroidal Injection of Triamcinolone Acetonide ...

Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL ...